// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Clinical Utility of a Novel Mathematical Solution for Assessment of Individual Lesion Contribution in Serial Coronary Artery Disease

Bhavik Modi - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Prognostic Implications of Reduced Pre-procedural TIMI Flow in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing PCI

Mordechai Golomb - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Long-term Outcomes of Saphenous Vein Graft Percutaneous Coronary Intervention

Novalia Sidik - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Defining Coronary Responders of Intra-aortic Balloon Pump Counterpulsation

Natalia Briceno - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lower mortality after clinically significant bleeding in patients treated with reversible P2Y12 agent Ticagrelor: A comparative, all-comers, prospective, 2-year follow up study in patients treated with invasive strategy after acute coronary syndrome

Girish Viswanathan - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Clopidogrel bisulfate

Long-Term Impact of Improving Drug-Eluting Stent Technology in Patients Undergoing Multilesion Intervention: A Patient-Level Analysis of 19 Randomized Trials

Paul Guedeney - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Long-term performance of the Dual-therapy COMBO stent: results from the REMEDEE Registry

Laura Kerkmeijer - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute Coronary Syndromes

sirolimus

GLP-1 does not protect against right ventricular stunning or cumulative ischemic dysfunction following right coronary artery balloon occlusion in humans.

Joel Giblett - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The GlucagOn-like peptide 1 Loading During PCI (GOLD PCI) trial: 12-month clinical outcomes

Joel Giblett - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Intranasal glucagon

A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent: Subgroup Analysis of the TARGET All Comers Trial

Alexandra Lansky - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Rapacan

Complex High and Indicated Percutaneous Coronary Indication: Does Operator Volume Influence Patient Outcome?

Tim Kinnaird - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic total occlusion

N/A

Twelve-Month Clinical Outcomes Comparing Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Coronary Stents in Patients With De Novo Native Coronary Artery Lesions: The meriT-V Randomized Trial

Alexandre Abizaid - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary artery lesions

sirolimus

Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A Sub-analysis of the SYNTAX II study

Rodrigo Modolo - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Could the logistic clinical SYNTAX score have predicted the all-cause mortality in the Global Leaders trial? A prediction prior to the unblinding of the trial

Ply Chichareon - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Paravalvular leak in the RESPOND post-market study: predictors and impact on 2-year clinical outcomes following TAVR with a fully repositionable and retrievable aortic valve in routine clinical practice

Jochen Wohrle - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials

Paul Guedeney - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Cardiovascular and Non-Cardiovascular Death After PCI: Insights From 32,882 Patients Enrolled in 21 Randomized Trials

Sorin Brener - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acute mechanical unloading of the left ventricle increases ‘functional perfusion’ of the area at risk by enhancing the collateral flow index prior to reperfusion

Natalia Briceno - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of PSP and other Elements of Technique on 3 Year Outcomes Among Metallic Everolimus-Eluting Stent-Treated Patients in the ABSORB Trials

Stephen Ellis - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Coronary perforation complicating percutaneous coronary intervention in patients presenting with an acute coronary syndrome: an analysis of 1,013 perforation cases from the British Cardiovascular Intervention Society database

Tim Kinnaird - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Copyright © 2026. QuantiNova All rights reserved